[Pharmacological studies of a lipase, GA-56, produced by Pseudomonas sp. IV. Chronic toxicity of GA-56].
D000284:Administration, Oral; D000818:Animals; D001772:Blood Cell Count; D001774:Blood Chemical Analysis; D001835:Body Weight / Q000187:drug effects; D001921:Brain / Q000473:pathology; D004435:Eating; D005243:Feces / Q000032:analysis; D007421:Intestine, Small / Q000473:pathology; D007668:Kidney / Q000473:pathology; D008049:Lipase / Q000008:administration & dosage / Q000633:toxicity*; D008099:Liver / Q000473:pathology; D008168:Lung / Q000473:pathology; D008297:Male; D009206:Myocardium / Q000473:pathology; D009929:Organ Size; D010179:Pancreas / Q000473:pathology; D011549:Pseudomonas / Q000201:enzymology*; D051381:Rats; D013154:Spleen / Q000473:pathology; D013270:Stomach / Q000473:pathology; D013737:Testis / Q000473:pathology; D000637:Transaminases / Q000097:blood; D001743:Urinary Bladder / Q000473:pathology; D014556:Urine / Q000032:analysis
D000637:Transaminases; D008049:Lipase